Deutsch English Français

Contact

EP2172227

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2172227

EP2172227 - Methods for reducing adventitious agents or toxins in a sample and cell culture reagents produced thereby [Right-click to bookmark this link]
Status	The application has been withdrawn Status updated on 10.06.2011 Database last updated on 14.09.2024
Most recent event Tooltip	10.06.2011	Withdrawal of application	published on 13.07.2011 [2011/28]
Applicant(s)	For all designated states Life Technologies Corporation 5823 Newton Drive Carlsbad, CA 92008 / US
	[N/P]
Former [2010/14]	For all designated states Life Technologies Corporation 5791 Van Allen Way Carlsbad, CA 92008 / US
Inventor(s)	01 / Biddle, William C. 54 Whitehall Avenue Buffalo, NY 14220 / US
	02 / Fike, Richard M. 9310 Hunting Valley Road Clarence, NY 14031 / US
	03 / Dadey, Barbara M. 143 Brooklea Drive East Aurora, NY 14052 / US
	04 / Bulera, Thomas E. 42 Wilkshire Place Lancaster, NY 14086-2704 / US
	[2010/14]
Representative(s)	HGF 1 City Walk Leeds LS11 9DX / GB
	[N/P]
Former [2010/14]	Harrison Goddard Foote Belgrave Hall Belgrave Street Leeds LS2 8DD / GB
Application number, filing date	09180485.6	30.06.1999
	[2010/14]
Priority number, date	US19980091275P	30.06.1998 Original published format: US 91275 P
	[2010/14]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	EP2172227
	Date:	07.04.2010
	Language:	EN
	[2010/46]
	Type:	A9 Corrected patent application
	No.:	EP2172227
	Date:	17.11.2010
	[2010/46]
	Type:	A3 Search report
	No.:	EP2172227
	Date:	19.01.2011
	[2011/03]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	05.03.2010
Classification	IPC:	A61L2/20, A61L2/06, C12N1/00, C12N5/00, F26B3/12	[2011/03]
	CPC:	F26B3/12 (EP); A61L2/0094 (EP); A61L2/20 (EP)
	Former IPC [2010/14]	A61L2/20, A61L2/06, F26B3/12
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2010/14]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	Verfahren zur Reduzierung von schädlichen Stoffen oder Toxinen in einer Probe und dadurch produzierte Zellkulturreagenzien	[2010/14]
	English:	Methods for reducing adventitious agents or toxins in a sample and cell culture reagents produced thereby	[2010/14]
	French:	Procédés servant à reduire des agents adventicés ou des toxines dans un échantillon et réactifs de cultures cellulaires obtenus par ce procédé	[2010/14]
Examination procedure	07.10.2010	Examination requested [2011/10]
	17.12.2010	New documents discovered [2011/16]
	07.06.2011	Application withdrawn by applicant [2011/28]
Parent application(s) Tooltip	EP99933615.9 / EP1091765
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP19990933615) is 17.03.2008
Fees paid	Renewal fee
	22.12.2009	Renewal fee patent year 03
	22.12.2009	Renewal fee patent year 04
	22.12.2009	Renewal fee patent year 05
	22.12.2009	Renewal fee patent year 06
	22.12.2009	Renewal fee patent year 07
	22.12.2009	Renewal fee patent year 08
	22.12.2009	Renewal fee patent year 09
	22.12.2009	Renewal fee patent year 10
	22.12.2009	Renewal fee patent year 11
	25.06.2010	Renewal fee patent year 12
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]WO9738734 (ACANOVA AB [SE], et al) [X] 1,2,4,9,13-15 * page 1, line 2 - line 8 * * page 3, line 2 - line 16 * * page 3, line 24 - page 6, line 10; figure 2 *;
		[X]WO9742980 (QUADRANT HOLDINGS CAMBRIDGE [GB], et al) [X] 1-16,18,19 * page 1, paragraph 1 * * page 9, line 13 - page 14, line 24; examples 1-4; claims 1, 21, 34, 40-43 *;
		[X]US4632980 (ZEE YUAN C [US], et al) [X] 1,2,4,8,9,13-16 * column 1, line 43 - column 4, line 17; claims 1-6 *;
		[X]US5700426 (SCHMITTHAEUSLER ROLAND [FR], et al) [X] 1-16,18,19 * column 2, line 8 - column 5, line 57; examples I-XI; claims 1,3 *;
		[X]JPH04198137 (SUMITOMO PHARMA) [X] 1-12 * abstract *;
		[X]WO9815297 (LIFETECH CORP [CA]) [X] 1-6,8,9,13-17 * page 5, line 4 - page 7, line 2 * * page 9, line 14 - page 25, line 12; examples 1-8 *;
		[X]WO9222637 (LIFE TECHNOLOGIES INC [US]) [X] 1-4,8,9,13-16 * page 1, line 3 - line 8 * * page 8, line 3 - page 30; examples I-VII; claims 1-26, 35-39 *;
		[XP]WO9836051 (LIFE TECHNOLOGIES INC [US]) [XP] 1-19 * page 1, line 4 - line 21 * * page 6, line 6 - page 9, line 11 * * page 12, line 15 - page 38, line 24; examples 1-16; claims 1-47,73-91 *
		[X] - DOWNES T.E.H. ET AL., "The relative nutritive value of irradiated spray-dried blood powder and heat-sterilized blood meal as measured in combination with whey protein", SOUTH AFRICAN JOURNAL OF ANIMAL SCIENCE, (1987), vol. 17, no. 2, pages 55 - 58, XP001008128 [X] 1-16,18,19 * page 55 - page 58 *
	by applicant	US4673649
		US5474931
		US3771237
		US4885848
		US5133137
		US5357688
		US5392531
		WO9513867
		US5006204
		US4511592
		US4689297
		DK167090B
		US5325606
		- RINGER, S, J PHYSIOL., vol. 3, pages 380 - 393
		- WAYRNOUTH, C., Cells and Tissues in Culture, ACADEMIC PRESS, (1965), vol. 1, pages 99 - 142
		- WAYMOUTH, C., IN VITRO, (1970), vol. 6, pages 109 - 127
		- COHEN, S., J. BIOL. CHERN, (1961), vol. 237, pages 1555 - 1565
		- PEEHL, D.M.; HAM, R.G., IN VITRO, (1980), vol. 16, pages 516 - 525
		- MACIAG, T. ET AL., PROC. NATL. ACAD. SCI. USA, (1979), vol. 76, pages 5674 - 5678
		- GILCHREST, B.A. ET AL., J. CELL. PHYSIOL, (1984), vol. 120, pages 377 - 383
		- BARRETAULT, D. ET AL., DIFFERENTIATION, (1981), vol. 18, pages 29 - 42
		- MACIAG, T. ET AL., SCIENCE, (1981), vol. 211, pages 1452 - 1454
		- LAMBERT, K.J. ET AL., Animal Cell Biotechnology, ACADEMIC PRESS, (1985), vol. 1, pages 85 - 122
		- E. KURSTAK AND C. KURSTAK,, Comparative Diagnosis of Viral Diseases, ACADEMIC PRESS, vol. I-IV
		- A. SAMIY, L. SMITH, K, J. WYNGAARDEN, Medical Microbiology and Infectious Diseases, W.B. SAUNDERS CO., vol. II
		- A. SAMIY, L. SMITH, JR., J. WYNGAARDEN, Medical Microbiology and infectious Diseases, W.B. SAUNDERS CO., vol. II
		- A. SAMIY, L. SMITH, JR., J. WYNGAARDEN, Medical Microbiology and Infectious Diseases, W.B. SAUNDERS CO., vol. 11
		- FRESHNEY, R.I., Culture ojAnimal Cells, ALAN R. LISS, INC., (1983), pages 74 - 78
		- HARLOW, E.; LANE, D., Antibodies: A Laboratory Manual, COLD SPRING HARBOR LABORATORY, (1988), pages 116 - 120
		- pyrogens, Endotoxins, LAL Testing, Depyrogenation, MARCEL DEKKER, INC.

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p